Stocktoria

MetaVia Inc. MTVA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2016-08-05

MetaVia Inc. statistics & valuation

Market cap$7.4M
P / B1.4×
Return on capital-250.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-70.70% -133660.00% -173.40% -412.00% -104.70% -64.20% -74.70% -347.90% -243.30% 2016201720182019202020212022202320242025
Shares outstanding
9.3M 10.6M 5.2M 15.6M 19.7M 888693 3.2M 5.1M 785194 2.3M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-58.90% -175.70% -406.50% -147.30% -270.60% -91.00% -41.70% -54.70% -169.70% -116.60% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$1.83 -$19.81 -$43.42 -$2.46 -$39.13 -$7.35 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-116.6%-169.7%-54.7%-41.7%-91.0%-270.6%-147.3%-406.5%-175.7%-58.9%
Return on equity-243.3%-347.9%-74.7%-64.2%-104.7%-412.0%-173.4%116.9%-133660.0%-70.7%
Current ratio1.931.943.782.857.692.896.7817.392.976.00

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.